Lung Cancer. We are dedicated to investigating the causes and progression of lung cancer. We focus on understanding how environmental factors like air pollution and lifestyle choices, particularly cigarette smoking, contribute to the development of lung cancer

Our work spans from basic science to clinical applications, aiming to improve prevention, diagnosis, and treatment of lung cancer and other respiratory diseases.

Key Areas of Research

1. Nanomedicine for Lung Cancer Treatment
Professor Oliver develops innovative nanomedicines to improve the delivery and effectiveness of lung cancer therapies. His work includes:

• Polysaccharide-Based Nanomedicines: Designed to enhance treatment outcomes for lung cancer.

• Berberine-Loaded Liquid Crystalline Nanoparticles: These nanoparticles inhibit the growth and spread of non-small cell lung cancer cells in laboratory studies.

2. Environmental Impacts on Lung Cancer
Professor Oliver investigates how environmental factors contribute to lung cancer development:

• Air Pollution (PM2.5): Studies show that low-level exposure can damage airways and impair lung function, potentially promoting cancer progression.

• Epidemiological Research: Collaborative studies link airborne particulate matter to increased lung cancer incidence and mortality.

3. Molecular Mechanisms and Biomarkers
His research explores the molecular drivers of lung cancer, including:

• MicroRNA Expression: Identifying specific microRNAs involved in lung adenocarcinoma, which could serve as diagnostic and prognostic biomarkers.

Learn more:

• ResearchGate Profile

• Woolcock Institute – Professor Brian Oliver